Your browser doesn't support javascript.
loading
Allogeneic Hematopoietic Stem Cell Transplantation for Adult Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Second Complete Remission.
Kaito, Satoshi; Kurosawa, Shuhei; Najima, Yuho; Sakaida, Emiko; Shingai, Naoki; Fukuda, Takahiro; Tachibana, Takayoshi; Uchida, Naoyuki; Ozawa, Yukiyasu; Sawa, Masashi; Nakazawa, Hideyuki; Ota, Shuichi; Kato, Jun; Nakamae, Hirohisa; Katayama, Yuta; Eto, Tetsuya; Tanaka, Junji; Kanda, Yoshinobu; Atsuta, Yoshiko; Arai, Yasuyuki; Kako, Shinichi.
Afiliação
  • Kaito S; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Electronic address: kaitosatoshi1223@gmail.com.
  • Kurosawa S; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Sakaida E; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Shingai N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Tachibana T; Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan.
  • Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
  • Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Aichi, Japan.
  • Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Aichi, Japan.
  • Nakazawa H; Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Nagano, Japan.
  • Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Hokkaido, Japan.
  • Kato J; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Nakamae H; Hematology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Katayama Y; Department of Hematology, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
  • Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
  • Tanaka J; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
  • Kanda Y; Division of Hematology, Jichi Medical University, Tochigi, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Aichi, Japan.
  • Arai Y; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
  • Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Transplant Cell Ther ; 28(6): 326.e1-326.e10, 2022 06.
Article em En | MEDLINE | ID: mdl-35306218
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article